← All trials
NCT00470496
Phase 1Interventional
Includes initial studies to determine the metabolism and pharmacologic actions of drugs in humans, the side effects associated with increasing doses, and to gain early evidence of effectiveness; may include healthy participants and/or patients.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Oct 19, 2006
- Primary completion
- Oct 28, 2011
- Completion date
- Oct 1, 2018
- First posted
- —
- Last posted
- —
- Enrollment
- 15
- Arms / groups
- 1 / —
- Source
- AACT · pre-existing
Sponsors
- State University of New York, BuffaloLead sponsor
- National Cancer Institute (NCI)Collaborator
- State University of New York, BuffaloOverall official - principal investigator
Drugs studied
Indications studied
- Squamous Cell Carcinoma of Head and Neck
- Basal Cell Carcinoma
- Carcinoma, Squamous Cell
- Carcinoma, Adenoid Cystic
- Graft vs Host Disease
- Granuloma
- Nasopharyngeal Neoplasms
- Neoplasm Metastasis
- Neuroblastoma
- Oropharyngeal Neoplasms
- Salivary Gland Neoplasms
- Thyroid Neoplasms
- Carcinoma, Mucoepidermoid
- Carcinoma, Verrucous
- Papilloma, Inverted
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.